One approved use, with clear limits
Is PT-141 FDA-Approved? Yes, for One Use
You'll see which women are covered, so you can spot claims that go too far.
Who does FDA approval cover?
Scientists reached PT-141 through tanning-drug research. They wanted to test the sexual effects they had noticed. That work produced bremelanotide.
FDA approved one PT-141 use on June 21, 2019 [7]. It is for some women distressed by low desire. The approval isn't broad.
Men aren't covered by the approval. Women after menopause aren't covered either. Weight loss and "performance" uses also lack approval [7].
Doctors sometimes prescribe a drug for a use FDA hasn't approved. That's called off-label use. FDA didn't review that use for approval.
PT-141 sold for research misses normal pharmacy checks [7]. An unchecked vial may contain a different drug, the wrong strength, or unwanted matter. You won't know for sure what enters your body.
Which women fit the approved use?
FDA approved the drug on June 21, 2019 [7]. Only women who haven't reached menopause can fit the approved use. Low desire has to cause real distress.
A woman's desire must once have felt normal. Doctors call that acquired, meaning the problem began later. The low desire must also trouble her.
Generalized means the problem can't be limited to one partner or one kind of touch. A woman may still have one partner. Both acquired and generalized must apply.
Two main trials included 1,267 women. Compared with placebo, desire went up and distress went down [3]. A 52-week follow-up showed that the benefit held [4].
The label lists 1.75 mg under the skin [7]. It's used when needed. This is PT-141's only approved use.
Broader claims appear online. The approval record doesn't support them. It closely names the women and health problem.
Which uses lack FDA approval?
Use in men isn't approved. Early work recorded erections, but FDA approval never followed [1][9][11]. Use after menopause also lacks approval.
Researchers also studied weight and hunger. The same brain area helps guide hunger. In Phase 1 work, food intake and weight both fell for some women [8].
Those studies used far more drug. They didn't lead to approval for weight loss. An early finding isn't the same as approval.
For you, "unapproved" has a clear meaning. FDA hasn't reviewed that use for approval. The word doesn't prove that the use works.
Can a research vial match the approved shot?
You can't assume it does. An FDA-approved shot must pass drug checks [7]. A "PT-141" research vial doesn't get those checks.
A research vial may not hold the same drug. You may not know its strength or purity [7]. Human studies don't prove that an unchecked vial is safe.
That doubt comes before any hoped-for gain. The label tells you what's in an approved shot. An unchecked seller can't offer the same proof.
The name PT-141 on a vial isn't enough. Approval belongs to the checked prescription drug. The approval doesn't follow the name onto every vial.
Why do these approval limits matter?
The words "FDA-approved" need their full meaning. They cover one PT-141 use before menopause. They also cover a checked prescription shot [7].
Use in men, later life, weight loss, or performance is different. A research vial is different too. The approved safety facts don't carry over [7].
These pages explain the label and studies. They can't choose for you. Your doctor can weigh your health against the approved use [7].
Ask one plain question when a claim sounds broad. Which exact use did FDA approve? That answer keeps the limit clear.